Antibiotics Active Pharmaceutical Ingredient (API) Market
Market Insights on Antibiotics Active Pharmaceutical Ingredient (API) covering sales outlook, demand forecast & up-to-date key trends
Antibiotics Active Pharmaceutical Ingredient (API) Market by API Type (Penicillin Antibiotics, Cephalosporins, Carbapenem Antibiotics), End User & Region - Forecast to 2020-2030
About the Report
Antibiotics are a group of medicines used to treat infections caused by germs or parasites by inhibiting their growth or by destroying them. Antibiotics are normally prescribed for patients suffering from serious bacterial or parasitic infections. Surging healthcare spending, in addition to rising demand for generic drugs will aid expansion of the market.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for antibiotics API. The report tracks the global sales of antibiotics API in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the pharmaceuticals industry in general, and antibiotic API in particular.
Let us know your requirement to get
100% FREE customization
How the Historic and Future Outlook of Antibiotics API Market Match Up?
The increasing antibiotics consumption has been fuelling the demand for antibiotics API across the world. India exhibits the highest human antibiotic consumption in the world. It is reported that antibiotic consumption in India has increased from 3.2 billion DDDs to 6.5 billion DDDs in 2015.
South Korea holds the eighth-highest position of antibiotic consumption globally, as per the World Health Organization (WHO). The consumption estimates around 27.68 defined daily doses per 1000 people. According to OECD data, in Europe’s community (i.e. outside of hospitals), the mean consumption of antibiotics was found to be 18.9 defined daily doses (DDDs) per 1000 inhabitants per day, ranging from 8.9 in the Netherlands and 32.1 in Greece in the year 2017.
According to FMI’s analysis, antibiotics API sales increased from US$ 7.0 Bn in 2015 to US$ 7.9 Bn in 2019. The pandemic has impacted several industries with the complete lockdown imposed after its outbreak. The demand and supplies of antibiotics API were impacted as well, leading to a sluggish growth.
The focus on research and development (R&D) activities within the healthcare sector is shifted onto the development of the COVID-19 vaccine. The majority of the research funds and investments were channelled for the COVID-19 vaccine development only. However, the antibiotics API demand is expected leverage from the current dip in the growth trend, with the reopening of the economies and market. FMI expects global antibiotics API demand to grow at 3.1% CAGR through 2030.
How is Growing Approval for Generics Expected to Influence Antibiotics API Demand?
Although new drugs continue to be licensed, only a few are based on novel chemical entities. Drug resistance is more likely to occur when new agents are variants of existing classes. Developing new entity is an expensive and a time-consuming process. Thus, due to the high cost and expenses involved the healthcare sector is now relying on generic antibiotics which accounts for about maximum number of prescriptions.
Generic antibiotics are considerably cheap in comparison to the proprietary compounds. Studies suggest, branded therapies are more than 3 times costlier than generic therapy in 36 (52.9 %) regimens for bacterial infection treatment. This has been encouraging the launch of generic versions, which is expected to bode well for the global market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhy Development of Advanced Molecules is key to Antibiotics API Market Growth?
Some of the leading biotechnology companies operating in the market are launching new sequencing products and expand the product portfolio, which is expected to indirectly increase the revenue of antibiotic API producers. The need for new classes of antibiotics to foster advanced medical procedures to address multidrug resistant effect and rising incidence of bacterial resistance led biotechnology companies to invest more in research and development.
Thus, the interest among biotechnology companies to develop advanced antibiotic molecule to sustain pipeline of new antibiotics is piqued. This has been creating opportunity for companies to strengthen their footprint in the market.
How is Antibiotics API Market Reforming?
Majority of the pharmaceutical companies have stopped investing in R&D for antibiotics years ago due to the market failures. Since, investment in R&D is crucial and urgently needed, addressing the current market failures through policy reform is imperative to build a viable growth opportunities. Governments have introduced various reforms for their reimbursement systems to address these market failures.
For instance, the U.K. is currently piloting a “delinkage” model wherein the National Health Service pays companies according to its value to the health system, rather than by the volume of the product used.
Collaboration and exchange of new and innovative models for reimbursing new antibiotics is an emerging trend among leading manufacturers. For instance, International platforms such as the Organization for Economic Co-operation and Development (OECD), Asia-Pacific Economic Cooperation (APEC), and the G20 are supporting to reform the innovative policy needed to build a sustainable market for new antibiotics.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Insights
How big is the Opportunity in US?
In the U.S., the healthcare system is well known for its expenditure and advanced infrastructure. Government and regulatory bodies of U.S. are adopting various cost-effective plans to reduce their healthcare burden. Furthermore, due to the higher prevalence of bacterial diseases, the demand for antibiotics API is increasing.
According to a report by Centers of Disease Control and Prevention (CDC), more than 2.8 million antibiotic-resistant infections occur in the U.S. each year. The government is adopting various prevention and infection control efforts in the U.S. to reduce the number of infections and deaths caused by antibiotic-resistant germs. This is creating a growth opportunity for the U.S. antibiotics API market.
What Drives Antibiotics API Market Germany?
The German healthcare industry is characterized by the presence of several key players. It is often influenced by the rising geriatric population and increasing focus on R&D. The Germany antibiotics API market is expected to reach 303.0 Mn by the end of 2030.
According to the Federal Statistical Office (Destatis), healthcare spending in Germany reached 390.6 billion euros or 4,712 euros per inhabitant, in 2018. With this, the country reported a 4% increase in healthcare spending than 2017. With these numbers set to rise further, Germany will continue offering lucrative opportunities for growth within Europe.
What is the Impact of Growing Contract Research Industry on India Antibiotics API Market?
In the recent years, small and large biopharmaceutical companies have become increasingly dependent on the contract research organization (CRO) sector to provide research services to their R&D operations. However, antibiotics API demand is expected to increase, as most products in the pipeline are likely to reach in the end stage and be commercialized by the end of the decade.
In developing countries it is easier to recruit patients for clinical trials. Clinical trial and research are now a major business in India owing to the presence of numerous government-funded medical and pharmaceutical institutions with state-of the-art facilities. This are ideal centers for multi-centered clinical trials.
R&D costs in India are substantially lesser than in developed countries, and it is possible to conduct both new drug discovery research and novel drug delivery system programs at competitive rates. In terms of cost efficiency, India is better as the cost to conduct a trial in the country is lesser by 50% to 75% as compared to that in the U.S. or the European Union.
What are the Restrains Faced by Turkey Market for Antibiotics API?
Developing new entity is more expensive and time consuming which can take about 10 years for development and upto US$ 1 Bn cost. Thus high cost of drug development and stringent process for regulatory approval are expected to hinder the Turkey antibiotics API market.
Lack of awareness about antibiotic utilization and indiscriminate use of antibiotics for non-serious infection can cause adverse side effects. Thus the rising side effects through lack of awareness and occurring resistance and other adverse side effects expects to hamper the growth of Turkey antibiotics API demand.
Category-wise Insights
Why Penicillin Antibiotics Dominate the Antibiotics API Market?
In terms of revenue, penicillin antibiotics is the dominant product segment in the global antibiotics API market in 2019. The penicillin antibiotics segment is expected to dominate the global antibiotics API market throughout the forecast period.
The increasing demand for and its adoption as a first-line antibiotic therapy to treat several bacterial infections are projected to fuel consumption of penicillin antibiotics worldwide. The penicillin antibiotics is likely to grow with a CAGR of 2.9%.
What’s the Revenue Share of Pharmaceutical Companies?
Pharmaceutical companies will continue exhibiting high demand and dominate the antibiotics API market during the forecast period. According to FMI, the segment is expected to hold around 74.9% of the market share, in terms of end user, by the end of 2030. Pharmaceutical companies hold dominance in terms of revenue owing to the growing R&D investment.
Competitive Landscape
Companies operating in the antibiotics API are focusing on launch of generic drugs. For instance, Australia-based Mayne Pharma announced on 15 March 2018 that it had launched a generic version of doxycycline monohydrate immediate release (IR) capsules (50, 75 and 100 mg) in the US.
Besides this there also is focus on product launches. For instance, in October 2017, CordenPharma acquired API site from Pfizer, Inc., which formerly belonged to the Hospira Boulder (Colorado) high containment API to shape their position in the leading competitive market.
Some of the leading companies operating in the antibiotics API market are:
- Sandoz International GmbH
- Centrient Pharmaceuticals
- CordenPharma International
- ACS DOBFAR SPA
- Nanjing Dorra Pharmaceutical Technology Co. Ltd.
- DAEWOONG PHARMACEUTICAL CO. LTD.
- Parabolic Drugs Ltd.
- Penam Laboratories Ltd.
- ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD.
- Fresenius Kabi
- The United Laboratories International Holdings Limited
- Aurobindo Pharma Limited
- Unimark Remedies Ltd.
- Savior Lifetec
- Shenzhen Haibin Pharmaceutical Co., Ltd.
- Sterile India Pvt. Ltd.
- Zhejiang Jiuzhou Pharmaceutical Co. Ltd.
- Kyongbo Pharm
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2020-2030 |
|
Historical Data Available for |
2015-2019 |
|
Market Analysis |
USD Million for Value |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
|
Key Segments Covered |
API, End User, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Antibiotics API Market by API Type
API Type
- Penicillin Antibiotics
- Ampicillin
- Amoxicillin
- Dicloxacillin
- Penicillin G Sodium
- Benzathine
- Procaine
- Cephalosporins
- Cefotaxime
- Ceftriaxone
- Cefuroxime
- Cefalotin
- Carbapenem Antibiotics
- Meropenem
- Imipenem
- Ertapenem
End User
- Pharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Contract Development & Manufacturing Organizations (CDMOs)
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East and Africa (MEA)
- Oceania
Frequently Asked Questions
China currently leads the global market for antibiotics API. Sales in China will be around 22% of total global demand throughout the forecast period.
Penicillin antibiotics are dominating the product type segment.
Some of the leading companies offering antibiotics API are Sandoz International GmbH, Centrient Pharmaceuticals, CordenPharma International, ACS DOBFAR SPA, Nanjing Dorra Pharmaceutical Technology Co. Ltd., DAEWOONG PHARMACEUTICAL CO. LTD., Parabolic Drugs Ltd., Penam Laboratories Ltd., ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD., Fresenius Kabi, The United Laboratories International Holdings Limited, Aurobindo Pharma Limited, Unimark Remedies Ltd., Savior Lifetec, Shenzhen Haibin Pharmaceutic
Pharmaceutical companies have emerged as leading end users of antibiotics API.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation /Development Trends
3.3. COVID19 Crisis Analysis
3.3.1. COVID19 and Impact Analysis
3.3.2. 2020 Market Scenario
3.3.3. Recovery Scenario- Short term, Midterm and Long Term Impact
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Expenditure Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Research and Developmental Activities
4.2.2. Product Formulation Advancement
4.2.3. Key Players Historical Growth
4.2.4. Market Consolidation Activities
4.2.5. Growing Investment by Key Players in Product Development
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. Market Context
5.1. Product USPs/ Features
5.2. Product Adoption / Usage Analysis
5.3. Regulatory Scenario
5.4. Supply-Chain Analysis
5.5. Consumption, By API Type (in Tons per Annum)
5.6. Pricing Analysis, BY API Type
6. Global Antibiotics API Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030, By API Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By API Type, 2015 - 2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By API Type, 2020–2030
7.3.1. Penicillin Antibiotics
7.3.1.1. Ampicillin
7.3.1.2. Amoxicillin
7.3.1.3. Dicloxacillin
7.3.1.4. Penicillin G Sodium
7.3.1.5. Benzathine
7.3.1.6. Procaine
7.3.2. Cephalosporins
7.3.2.1. Cefotaxime
7.3.2.2. Ceftriaxone
7.3.2.3. Cefuroxime
7.3.2.4. Cefalotin
7.3.3. Carbapenem Antibiotics
7.3.3.1. Meropenem
7.3.3.2. Imipenem
7.3.3.3. Ertapenem
8. Global Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By End User, 2015 - 2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020–203
8.3.1. Pharmaceutical Companies
8.3.2. Contract Manufacturing Organizations (CMOs)
8.3.3. Contract Development & Manufacturing Organizations (CDMOs)
8.4. Market Attractiveness Analysis By End User
9. Global Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020–2030
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By API Type
10.3.3. By End User
10.4. Market Attractiveness Analysis
10.5. Key Market Participants - Intensity Mapping
10.6. Drivers and Restraints - Impact Analysis
11. Latin America Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Argentina
11.3.1.4. Rest of Latin America
11.3.2. By API Type
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis
12. Europe Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. BENELUX
12.3.1.7. Russia
12.3.1.8. Rest of Europe
12.3.2. By API Type
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. South Asia Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030,
13.3.1. By Country
13.3.1.1. India
13.3.1.2. Thailand
13.3.1.3. ASEAN countries
13.3.1.4. Rest of South Asia
13.3.2. By API Type
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. East Asia Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By API Type
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Oceania Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
15.3.1. By Country
15.3.1.1. Australia
15.3.1.2. New Zealand
15.3.2. By API Type
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. South Africa
16.3.1.3. Rest of Middle East and Africa
16.3.2. By API Type
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Key and Emerging Countries Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. U.S. Antibiotics API Market Analysis
17.2.1. By API Type
17.2.2. By End User
17.3. Canada Antibiotics API Market Analysis
17.3.1. By API Type
17.3.2. By End User
17.4. Mexico Antibiotics API Market Analysis
17.4.1. By API Type
17.4.2. By End User
17.5. Brazil. Antibiotics API Market Analysis
17.5.1. By API Type
17.5.2. By End User
17.6. Argentina Antibiotics API Market Analysis
17.6.1. By API Type
17.6.2. By End User
17.7. U.K. Antibiotics API Market Analysis
17.7.1. By API Type
17.7.2. By End User
17.8. Germany Antibiotics API Market Analysis
17.8.1. By API Type
17.8.2. By End User
17.9. France Antibiotics API Market Analysis
17.9.1. By API Type
17.9.2. By End User
17.10. Italy Antibiotics API Market Analysis
17.10.1. By API Type
17.10.2. By End User
17.11. Spain Antibiotics API Market Analysis
17.11.1. By API Type
17.11.2. By End User
17.12. Russia Antibiotics API Market Analysis
17.12.1. By API Type
17.12.2. By End User
17.13. China Antibiotics API Market Analysis
17.13.1. By API Type
17.13.2. By End User
17.14. Japan Antibiotics API Market Analysis
17.14.1. By API Type
17.14.2. By End User
17.15. South Korea Antibiotics API Market Analysis
17.15.1. By API Type
17.15.2. By End User
17.16. India Antibiotics API Market Analysis
17.16.1. By API Type
17.16.2. By End User
17.17. Thailand Antibiotics API Market Analysis
17.17.1. By API Type
17.17.2. By End User
17.18. ASEAN Antibiotics API Market Analysis
17.18.1. By API Type
17.18.2. By End User
17.19. Australia Antibiotics API Market Analysis
17.19.1. By API Type
17.19.2. By End User
17.20. New Zealand Antibiotics API Market Analysis
17.20.1. By API Type
17.20.2. By End User
17.21. GCC Countries Antibiotics API Market Analysis
17.21.1. By API Type
17.21.2. By End User
17.22. Turkey Antibiotics API Market Analysis
17.22.1. By API Type
17.22.2. By End User
17.23. South Africa Antibiotics API Market Analysis
17.23.1. By API Type
17.23.2. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional Footprint of Players
18.4.2. API Type Footprint by Players
18.4.3. Channel Footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive (Tentative List)
19.3.1. Sandoz International GmbH
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Key Financial
19.3.1.4. Sales Footprint
19.3.1.5. Strategic Overview
19.3.2. Centrient Pharmaceuticals
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Key Financial
19.3.2.4. Sales Footprint
19.3.2.5. Strategic Overview
19.3.3. CordenPharma International
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Key Financial
19.3.3.4. Sales Footprint
19.3.3.5. Strategic Overview
19.3.4. ACS DOBFAR SPA
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Key Financial
19.3.4.4. Sales Footprint
19.3.4.5. Strategic Overview
19.3.5. Nanjing Dorra Pharmaceutical Technology Co. Ltd.
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Key Financial
19.3.5.4. Sales Footprint
19.3.5.5. Strategic Overview
19.3.6. DAEWOONG PHARMACEUTICAL CO. LTD.
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Key Financial
19.3.6.4. Sales Footprint
19.3.6.5. Strategic Overview
19.3.7. Parabolic Drugs Ltd.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Key Financial
19.3.7.4. Sales Footprint
19.3.7.5. Strategic Overview
19.3.8. Penam Laboratories Ltd.
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Key Financial
19.3.8.4. Sales Footprint
19.3.8.5. Strategic Overview
19.3.9. ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD.
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Key Financial
19.3.9.4. Sales Footprint
19.3.9.5. Strategic Overview
19.3.10. Fresenius Kabi
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Key Financial
19.3.10.4. Sales Footprint
19.3.10.5. Strategic Overview
19.3.11. The United Laboratories International Holdings Limited
19.3.11.1. Overview
19.3.11.2. Product Portfolio
19.3.11.3. Key Financial
19.3.11.4. Sales Footprint
19.3.11.5. Strategic Overview
19.3.12. Aurobindo Pharma Limited
19.3.12.1. Overview
19.3.12.2. Product Portfolio
19.3.12.3. Key Financial
19.3.12.4. Sales Footprint
19.3.12.5. Strategic Overview
19.3.13. Unimark Remedies Ltd.
19.3.13.1. Overview
19.3.13.2. Product Portfolio
19.3.13.3. Key Financial
19.3.13.4. Sales Footprint
19.3.13.5. Strategic Overview
19.3.14. Savior Lifetec
19.3.14.1. Overview
19.3.14.2. Product Portfolio
19.3.14.3. Key Financial
19.3.14.4. Sales Footprint
19.3.14.5. Strategic Overview
19.3.15. Shenzhen Haibin Pharmaceutical Co., Ltd.
19.3.15.1. Overview
19.3.15.2. Product Portfolio
19.3.15.3. Key Financial
19.3.15.4. Sales Footprint
19.3.15.5. Strategic Overview
19.3.16. Sterile India Pvt. Ltd.
19.3.16.1. Overview
19.3.16.2. Product Portfolio
19.3.16.3. Key Financial
19.3.16.4. Sales Footprint
19.3.16.5. Strategic Overview
19.3.17. Zhejiang Jiuzhou Pharmaceutical Co. Ltd.
19.3.17.1. Overview
19.3.17.2. Product Portfolio
19.3.17.3. Key Financial
19.3.17.4. Sales Footprint
19.3.17.5. Strategic Overview
19.3.18. Kyongbo Pharm
19.3.18.1. Overview
19.3.18.2. Product Portfolio
19.3.18.3. Key Financial
19.3.18.4. Sales Footprint
19.3.18.5. Strategic Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type
Table 02: Global Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 03: Global Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 04: North America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 05: North America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type
Table 06: North America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 07: Latin America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 08: Latin America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type
Table 09: Latin America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 10: Europe Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 11: Europe Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type
Table 12: Europe Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 13: South Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 14: South Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type
Table 15: South Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 16: East Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 17: East Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type
Table 18: East Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 19: Oceania Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 20: Oceania Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type
Table 21: Oceania Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 22: Middle East and Africa Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 23: Middle East and Africa Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type
Table 24: Middle East and Africa Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 02: Global Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 03: Global Antibiotics API Market Absolute $ Opportunity, 2020 - 2030
Figure 04: Global Antibiotics API Market Share Analysis (%), By API Type, 2020-2030
Figure 05: Global Antibiotics API Market Y-o-Y Analysis (%), By API Type, 2020-2030
Figure 06: Global Antibiotics API Market Attractiveness Analysis, By API Type, 2020-2030
Figure 07: Global Antibiotics API Market Share Analysis (%), By End User, 2020-2030
Figure 08: Global Antibiotics API Market Y-o-Y Analysis (%), By End User, 2020-2030
Figure 09: Global Antibiotics API Market Attractiveness Analysis by End User, 2020-2030
Figure 10: Global Antibiotics API Market Share Analysis (%), By Region, 2020-2030
Figure 11: Global Antibiotics API Market Y-o-Y Analysis (%), By Region, 2020-2030
Figure 12: Global Antibiotics API Market Attractiveness Analysis by Region, 2020-2030
Figure 13: North America Antibiotics API Market Value Share, By API Type, 2020 (E)
Figure 14: North America Antibiotics API Market Value Share, By End User, 2020 (E)
Figure 15: North America Antibiotics API Market Value Share, By Country, 2020 (E)
Figure 16: North America Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 17: North America Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 18: North America Antibiotics API Market Attractiveness Analysis by API Type, 2020 – 2030
Figure 19: North America Antibiotics API Market Attractiveness Analysis by End User, 2020- 2030
Figure 20: North America Antibiotics API Market Attractiveness Analysis by Country, 2020 - 2030
Figure 21: Latin America Antibiotics API Market Value Share, By API Type, 2020 (E)
Figure 22: Latin America Antibiotics API Market Value Share, By End User, 2020 (E)
Figure 23: Latin America Antibiotics API Market Value Share, By Country, 2020 (E)
Figure 24: Latin America Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 25: Latin America Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 26: Latin America Antibiotics API Market Attractiveness Analysis by API Type, 2020 - 2030
Figure 27: Latin America Antibiotics API Market Attractiveness Analysis by End User, 2020 -2030
Figure 28: Latin America Antibiotics API Market Attractiveness Analysis by Country, 2020-2030
Figure 29: Europe Antibiotics API Market Value Share, By API Type, 2020 (E)
Figure 30: Europe Antibiotics API Market Value Share, By End User, 2020 (E)
Figure 31: Europe Antibiotics API Market Value Share, By Country, 2020 (E)
Figure 32: Europe Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 33: Europe Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 34: Europe Antibiotics API Market Attractiveness Analysis by API Type, 2020-2030
Figure 35: Europe Antibiotics API Market Attractiveness Analysis by End User, 2020-2030
Figure 36: Europe Antibiotics API Market Attractiveness Analysis by Country, 2020-2030
Figure 37: South Asia Antibiotics API Market Value Share, By API Type, 2020 (E)
Figure 38: South Asia Antibiotics API Market Value Share, By End User, 2020 (E)
Figure 39: South Asia Antibiotics API Market Value Share, By Country, 2020 (E)
Figure 40: South Asia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 41: South Asia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 42: South Asia Antibiotics API Market Attractiveness Analysis, By API Type, 2020-2030
Figure 43: South Asia Antibiotics API Market Attractiveness Analysis, By End User, 2020-2030
Figure 44: South Asia Antibiotics API Market Attractiveness Analysis, By Country, 2020-2030
Figure 45: East Asia Antibiotics API Market Value Share, By API Type, 2020 (E)
Figure 46: East Asia Antibiotics API Market Value Share, By End User, 2020 (E)
Figure 47: East Asia Antibiotics API Market Value Share, By Country, 2020 (E)
Figure 48: East Asia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 49: East Asia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 50: East Asia Antibiotics API Market Attractiveness Analysis by API Type, 2020-2030
Figure 51: East Asia Antibiotics API Market Attractiveness Analysis by End User, 2020-2030
Figure 52: East Asia Antibiotics API Market Attractiveness Analysis by Country, 2020-2030
Figure 53: Oceania Antibiotics API Market Value Share, By API Type, 2020 (E)
Figure 54: Oceania Antibiotics API Market Value Share, By End User, 2020 (E)
Figure 55: Oceania Antibiotics API Market Value Share, By Country, 2020 (E)
Figure 56: Oceania Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 57: Oceania Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 58: Oceania Antibiotics API Market Attractiveness Analysis, By API Type, 2020-2030
Figure 59: Oceania Antibiotics API Market Attractiveness Analysis, By End User, 2020-2030
Figure 60: Oceania Antibiotics API Market Attractiveness Analysis by Country, 2020-2030
Figure 61: Middle East and Africa Antibiotics API Market Value Share, By API Type, 2020 (E)
Figure 62: Middle East and Africa Antibiotics API Market Value Share, By End User, 2020 (E)
Figure 63: Middle East and Africa Antibiotics API Market Value Share, By Country, 2020 (E)
Figure 64: Middle East and Africa Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 65: Middle East and Africa Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 66: Middle East and Africa Antibiotics API Market Attractiveness Analysis by API Type, 2020-2030
Figure 67: Middle East and Africa Antibiotics API Market Attractiveness Analysis, By End User, 2020-2030
Figure 68: Middle East and Africa Antibiotics API Market Attractiveness Analysis by Country, 2020-2030
Figure 69: U.S. Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 70: U.S. Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 71: U.S. Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 72: U.S Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 73: U.S Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 74: Canada Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 75: Canada Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 76: Canada Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 77: Canada Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 78: Canada Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 79: Mexico Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 80: Mexico Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 81: Mexico Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 82: Mexico Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 83: Mexico Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 84: Brazil Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 85: Brazil Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 86: Brazil Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 87: Brazil Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 88: Brazil Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 89: Argentina Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 90: Argentina Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 91: Argentina Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 92: Argentina Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 93: Argentina Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 94: U.K. Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 95: U.K. Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 96: U.K. Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 97: U.K. Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 98: U.K. Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 99: Germany Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 100: Germany Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 101: Germany Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 102: Germany Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 103: Germany Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 104: France Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 105: France Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 106: France Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 107: France Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 108: France Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 109: Italy Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 110: Italy Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 111: Italy Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 112: Italy Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 113: Italy Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 114: Spain Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 115: Spain Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 116: Spain Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 117: Spain Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 118: Spain Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 119: Russia Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 120: Russia Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 121: Russia Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 122: Russia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 123: Russia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 124: China Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 125: China Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 126: China Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 127: China Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 128: China Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 129: Japan Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 130: Japan Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 131: Japan Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 132: Japan Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 133: Japan Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 134: South Korea Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 135: South Korea Antibiotics API Market Value Share, By Aend User, 2020 & 2030
Figure 136: South Korea Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 137: South Korea Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 138: South Korea Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 139: India Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 140: India Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 141: India Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 142: India Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 143: India Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 144: Thailand Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 145: Thailand Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 146: Thailand Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 147: Thailand Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 148: Thailand Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 149: Malaysia Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 150: Malaysia Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 151: Malaysia Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 152: Malaysia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 153: Malaysia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 154: Indonesia Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 155: Indonesia Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 156: Indonesia Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 157: Indonesia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 158: Indonesia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 159: Australia Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 160: Australia Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 161: Australia Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 162: Australia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 163: Australia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 164: New Zealand Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 165: New Zealand Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 166: New Zealand Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 167: New Zealand Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 168: New Zealand Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 169: GCC Countries Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 170: GCC Countries Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 171: GCC Countries Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 172: GCC Countries Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 173: GCC Countries Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 174: Turkey Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 175: Turkey Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 176: Turkey Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 177: Turkey Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 178: Turkey Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Figure 179: South Africa Antibiotics API Market Value Share, By API Type, 2020 & 2030
Figure 180: South Africa Antibiotics API Market Value Share, By End User, 2020 & 2030
Figure 181: South Africa Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030
Figure 182: South Africa Antibiotics API Market Value Analysis (US$ Mn), 2015-2019
Figure 183: South Africa Antibiotics API Market Value Forecast (US$ Mn), 2020-2030
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
